Hugo Kohnke

Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate

Cavalli, Marco; Eriksson, Niclas; Karlsson Sundbaum, Johanna; Wallenberg, Matilda et al.

Part of Pharmacogenomics (London), p. 813-820, 2022

• DOI for Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate
• Download full text (pdf) of Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate

Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Karlsson Sundbaum, Johanna; Baecklund, Eva; Eriksson, Niclas; Kohnke, Hugo et al.

Part of Pharmacogenomics (London), p. 973-982, 2021

• DOI for Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate
• Download full text (pdf) of Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Fördelaktigt med genetisk analys före behandling med 5-fluorouracil: Utvärdering tyder på mindre biverkningar och kostnadsbesparing för sjukvården: [New recommendation on pharmacogenetic screening prior to 5-fluorouracil based cancer treatment - Swedish experience indicates less adverse effects and healthcare cost savings]

Schultz, Alice; Kohnke, Hugo; Wadelius, Mia; Nygren, Peter

Part of Läkartidningen, 2021

Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.

Rasmussen, Eva Rye; Hallberg, Pär; Baranova, Ekaterina V; Eriksson, Niclas et al.

Part of The Pharmacogenomics Journal, p. 770-783, 2020

• DOI for Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
• Download full text (pdf) of Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.

MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Karlsson Sundbaum, Johanna; Baecklund, Eva; Eriksson, Niclas; Hallberg, Pär et al.

Part of Pharmacogenomics (London), p. 337-346, 2020

• DOI for MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate

Cavalli, Marco; Eriksson, Niclas; Karlsson Sundbaum, Johanna; Wallenberg, Matilda et al.

Part of Pharmacogenomics (London), p. 813-820, 2022

• DOI for Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate
• Download full text (pdf) of Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate

Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Karlsson Sundbaum, Johanna; Baecklund, Eva; Eriksson, Niclas; Kohnke, Hugo et al.

Part of Pharmacogenomics (London), p. 973-982, 2021

• DOI for Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate
• Download full text (pdf) of Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Fördelaktigt med genetisk analys före behandling med 5-fluorouracil: Utvärdering tyder på mindre biverkningar och kostnadsbesparing för sjukvården: [New recommendation on pharmacogenetic screening prior to 5-fluorouracil based cancer treatment - Swedish experience indicates less adverse effects and healthcare cost savings]

Schultz, Alice; Kohnke, Hugo; Wadelius, Mia; Nygren, Peter

Part of Läkartidningen, 2021

Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.

Rasmussen, Eva Rye; Hallberg, Pär; Baranova, Ekaterina V; Eriksson, Niclas et al.

Part of The Pharmacogenomics Journal, p. 770-783, 2020

• DOI for Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
• Download full text (pdf) of Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.

MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Karlsson Sundbaum, Johanna; Baecklund, Eva; Eriksson, Niclas; Hallberg, Pär et al.

Part of Pharmacogenomics (London), p. 337-346, 2020

• DOI for MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival

Hallberg, Pär; Smedje, Hans; Eriksson, Niclas; Kohnke, Hugo et al.

Part of EBioMedicine, p. 595-604, 2019

• DOI for Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival
• Download full text (pdf) of Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival

Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.

Wadelius, Mia; Eriksson, Niclas; Kreutz, Reinhold; Bondon-Guitton, Emmanuelle et al.

Part of Clinical Pharmacology and Therapeutics, p. 843-853, 2018

• DOI for Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.
• Download full text (pdf) of Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.

Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer

Glimelius, Bengt; Garmo, Hans; Berglund, Åke; Fredriksson, L. A. et al.

Part of The Pharmacogenomics Journal, p. 61-71, 2011

• DOI for Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer

Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes

Howard, Rebecca; Leathart, Julian B S; French, David J; Krishan, Elaina et al.

Part of Clinica Chimica Acta, p. 2063-2069, 2011

• DOI for Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes

Rapid Single-Nucleotide Polymorphism Detection of Cytochrome P450 (CYP2C9) and Vitamin K Epoxide Reductase (VKORC1) Genes for the Warfarin Dose Adjustment by the SMart-Amplification Process Version 2

Aomori, Tohru; Yamamoto, Koujirou; Oguchi-Katayama, Atsuko; Kawai, Yuki et al.

Part of Clinical Chemistry, p. 804-812, 2009

• DOI for Rapid Single-Nucleotide Polymorphism Detection of Cytochrome P450 (CYP2C9) and Vitamin K Epoxide Reductase (VKORC1) Genes for the Warfarin Dose Adjustment by the SMart-Amplification Process Version 2